Page 263 - EJMO-9-1
P. 263

Eurasian Journal of
            Medicine and Oncology                              Quality of life, somatosensory amplification, and stress in ADPKD



               doi: 10.1007/s00467-024-06571-7                 27.  Prihodova L, Nagyova I, Rosenberger J, Roland R, Van Dijk JP,
                                                                  Groothoff JW. Impact of personality and psychological
            16.  Alavi NM, Aliakbarzadeh Z, Sharifi K. Depression, anxiety,
               activities of daily living, and quality of life scores in patients   distress on health-related quality of life in kidney transplant
               undergoing renal replacement therapies.  Transplant Proc.   recipients. Transpl Int. 2010;23(5):484-492.
               2009;41(9):3693-3696.                              doi: 10.1111/j.1432-2277.2009.01003.x
               doi: 10.1016/j.transproceed.2009.06.217         28.  Hedayati SS, Minhajuddin AT, Toto RD, Morris DW,
                                                                  Rush AJ. Prevalence of major depressive episode in CKD.
            17.  Li C, Mao W, Liu X. Depression, anxiety and reduced quality
               of life in predialysis: Differences across the CKD stages? Int   Am J Kidney Dis. 2009;54(3):424-432.
               J Clin Pract. 2014;68(5):657-658.                  doi: 10.1053/j.ajkd.2009.03.017
               doi: 10.1111/ijcp.12422                         29.  Duarte PS, Miyazaki MC, Blay SL, Sesso R. Cognitive-
                                                                  behavioral group therapy is an effective treatment for
            18.  Latremoliere A, Woolf CJ. Central sensitization: A generator
               of pain hypersensitivity by central neural plasticity. J Pain.   major  depression  in  hemodialysis  patients.  Kidney Int.
               2009;10(9):895-926.                                2009;76(4):414-421.
                                                                  doi: 10.1038/ki.2009.156
               doi: 10.1016/j.jpain.2009.06.012
                                                               30.  Ware J Jr., Kosinski M, Keller SD. A  12-item short-form
            19.  Ferentzi E, Köteles F, Csala B, et al. What makes sense in
               our body? Personality and sensory correlates of body   health survey: Construction of scales and preliminary tests
               awareness and somatosensory amplification.  Pers Individ   of reliability and validity. Med Care. 1996;34(3):220-233.
               Dif. 2017;104:75-81.                               doi: 10.1097/00005650-199603000-00003
               doi: 10.1016/j.paid.2016.07.034                 31.  Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A. Reliability and
                                                                  validity of the SF-36 for the Turkish population. Ege Fizik
            20.  Keskin ET, Bozkurt M, Özdemir H,  et al. The severity
               of renal colic pain: Can it be predicted? Can Urol Assoc J.   Tedavi Rehabilitasyon Derg. 1999;12:102-106. [In Turkish].
               2023;17(9):E257-E262.                           32.  Barsky AJ, Wyshak G, Klerman GL. The somatosensory
                                                                  amplification scale and its relationship to hypochondriasis.
               doi: 10.5489/cuaj.8283
                                                                  J Psychiatr Res. 1990;24(4):323-334.
            21.  Kivrak Y, Kose-Ozlece H, Ustundag MF, Asoglu M.      doi: 10.1016/0022-3956(90)90004-a
               Pain perception:  Predictive  value  of sex, depression,
               anxiety, somatosensory amplification, obesity, and age.   33.  Güleç H, Sayar K. Reliability and validity of the Turkish
               Neuropsychiatr Dis Treat. 2016;12:1913-1918.       form of the somatosensory amplification scale.  Psychiatry
                                                                  Clin Neurosci. 2007;61(1):25-30.
               doi: 10.2147/NDT.S106974
                                                                  doi: 10.1111/j.1440-1819.2007.01606.x
            22.  Iliuta IA, Kalatharan V, Wang K,  et al. Polycystic kidney
               disease without an apparent family history. J Am Soc Nephrol.   34.  Eskin M, Harlak H, Demirkıran F, Dereboy Ç. Adaptation
               2017;28(9):2768-2776.                              of the perceived stress scale into Turkish: Reliability and
                                                                  validity analysis.  J  New  Symp.  2013;51(3):132-140. [In
               doi: 10.1681/ASN.2016090938
                                                                  Turkish].
            23.  Torres VE, Chapman AB, Devuyst O,  et al. Tolvaptan in   35.  Ma LC, Chang HJ, Liu YM, et al. The relationship between
               patients with autosomal dominant polycystic kidney disease.   health-promoting behaviors and resilience in patients
               N Engl J Med. 2012;367(25):2407-2418.
                                                                  with chronic kidney disease.  ScientificWorldJournal.
               doi: 10.1056/NEJMoa1205511                         2013;2013:124973.
            24.  Schneiderman N, Ironson G, Siegel SD. Stress and health:      doi: 10.1155/2013/124973
               Psychological, behavioral, and biological  determinants.   36.  Mapes DL, Lopes AA, Satayathum S, et al. Health-related
               Annu Rev Clin Psychol. 2005;1:607-628.
                                                                  quality of life as a predictor of mortality and hospitalization:
               doi: 10.1146/annurev.clinpsy.1.102803.144141       The dialysis outcomes and practice patterns study (DOPPS).
                                                                  Kidney Int. 2003;64(1):339-349.
            25.  Harris PC, Torres VE. Polycystic kidney disease. Annu Rev
               Med. 2009;60:321-337.                              doi: 10.1046/j.1523-1755.2003.00072.x
               doi: 10.1146/annurev.med.60.101707.125712       37.  Ecder T, Schrier RW. Hypertension in autosomal-dominant
            26.  Widjast EP, Halim  MS. Personality, coping strategy,  and   polycystic  kidney disease:  Early  occurrence and  unique
               quality of life of patients with chronic kidney disease.   aspects. J Am Soc Nephrol. 2001;12(1):194-200.
               J Psikol. 2021;48(3):199-213.                      doi: 10.1681/ASN.V121194
               doi: 10.22146/jpsi.37875                        38.  Cohen D, Timsit MO, Chrétien Y,  et al. Place de la


            Volume 9 Issue 1 (2025)                        255                              doi: 10.36922/ejmo.7550
   258   259   260   261   262   263   264   265   266   267   268